<p>An Italian guideline panel issued the national recommendations for breast cancer diagnosis, staging, and preoperative planning. The panel employed the ADOLOPMENT process to&#xa0;<i>adopt or adapt</i> the guidelines developed by the European Commission Initiative on Breast Cancer (ECIBC). This process utilises the Grading of Recommendations Assessment, Development and Evaluation evidence-to-decision framework. Hereby, we present 15 prioritised recommendations from the second chapter of the Italian guidelines. All of the recommendations as originally developed by the ECIBC were adopted. For the assessment of women with positive screening result, the diagnostic recommendations suggest using digital breast tomosynthesis instead of additional mammographic projections. Recommendations include using needle core biopsy (NCB) instead of fine-needle aspiration for suspicious lesions, and stereotactic-guided –rather than ultrasound-guided– NCB for suspicious calcifications. For preoperative planning, they recommend clip marking after biopsy and not using additional magnetic resonance imaging (MRI) for confirmed ductal carcinoma in situ. Contrast-enhanced mammography is preferred over MRI for presurgical planning, when needed. Other imaging tests are not recommended for stage I, IIa, and IIb BC without signs of metastasis, while positron emission tomography-computed tomography alone is suggested for stage III BC. Adjuvant hormone therapy is recommended when 1% or more tumour cells show oestrogen or progesterone receptor positivity, which replaces the 10% threshold. Adopting shared and trustworthy guidelines for BC screening across Europe will help standardise the process across settings and advance healthcare quality and equity.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Italian adaptation of the European guidelines for breast cancer diagnosis, staging, and preoperative planning: a GRADE-ADOLOPMENT approach

  • Paola Mantellini,
  • Andrea Guida,
  • Erika Del Prete,
  • Francesca Battisti,
  • Flori Degrassi,
  • Adriana Bonifacino,
  • Beniamino Brancato,
  • Cristian Scatena,
  • Livia Giordano,
  • Leopoldo Costarelli,
  • Alfredo Santinelli,
  • Catia Angiolini,
  • Francesca Pietribiasi,
  • Marco Zappa,
  • Prassede Foxi,
  • Matteo Capobussi,
  • Francesco Sardanelli,
  • Paolo Giorgi Rossi,
  • Lauro Bucchi,
  • Silvia Deandrea,
  • Vittorio Cannatà,
  • Isabella Castellano,
  • Gabriella Dardanoni,
  • Giulio Francolini,
  • Stefania Gori,
  • Carlo Magliocca,
  • Stefania Montemezzi,
  • Stefano Pacifici,
  • Emanuele Torri,
  • Annalisa Trianni,
  • Antonella Pellegrini,
  • Daniela Ambrogetti,
  • Paola Bellardini,
  • Laura Bonvicini,
  • Massimo Calabrese,
  • Stefano Campa,
  • Eva Carnesciali,
  • Francesca Caumo,
  • Valeria Fava,
  • Paola Golinelli,
  • Icro Meattini,
  • Marco Moschetta,
  • Paola Mosconi,
  • Eugenio Paci,
  • Loredana Pau,
  • Stella Pedilarco,
  • Marco Rosselli del Turco,
  • Marzia Salgarello,
  • Gioele Santucci,
  • Priscilla Sassoli de’ Bianchi,
  • Roberto Satolli,
  • Carlo Senore,
  • Margherita Serra,
  • Mario Taffurelli,
  • Antonio Rizzo,
  • Rubina Manuela Trimboli,
  • Marco Lucioni

摘要

An Italian guideline panel issued the national recommendations for breast cancer diagnosis, staging, and preoperative planning. The panel employed the ADOLOPMENT process to adopt or adapt the guidelines developed by the European Commission Initiative on Breast Cancer (ECIBC). This process utilises the Grading of Recommendations Assessment, Development and Evaluation evidence-to-decision framework. Hereby, we present 15 prioritised recommendations from the second chapter of the Italian guidelines. All of the recommendations as originally developed by the ECIBC were adopted. For the assessment of women with positive screening result, the diagnostic recommendations suggest using digital breast tomosynthesis instead of additional mammographic projections. Recommendations include using needle core biopsy (NCB) instead of fine-needle aspiration for suspicious lesions, and stereotactic-guided –rather than ultrasound-guided– NCB for suspicious calcifications. For preoperative planning, they recommend clip marking after biopsy and not using additional magnetic resonance imaging (MRI) for confirmed ductal carcinoma in situ. Contrast-enhanced mammography is preferred over MRI for presurgical planning, when needed. Other imaging tests are not recommended for stage I, IIa, and IIb BC without signs of metastasis, while positron emission tomography-computed tomography alone is suggested for stage III BC. Adjuvant hormone therapy is recommended when 1% or more tumour cells show oestrogen or progesterone receptor positivity, which replaces the 10% threshold. Adopting shared and trustworthy guidelines for BC screening across Europe will help standardise the process across settings and advance healthcare quality and equity.